DISTINCTIVE

seconD- line folfiri aflIbercept in proSpecTIvely stratified, anti-egfr resistaNt, metastatic coloreCTal  cancer patIents with ras validated wild typstatus (distinctive)

AFLIBERCEPT POST ANTI-EGFR IN CCR

· NEWSLETTER

Scarica il file  

· WCGI 2018

Scarica il file  

· SINOSSI

Scarica il file